Advaxis - Stock Price History | ADXS

Historical daily share price chart and data for Advaxis since 2020 adjusted for splits. The latest closing stock price for Advaxis as of October 27, 2020 is 0.39.
  • The all-time high Advaxis stock closing price was 937.03 on July 29, 2005.
  • The Advaxis 52-week high stock price is 1.48, which is 279.5% above the current share price.
  • The Advaxis 52-week low stock price is 0.28, which is 28.2% below the current share price.
  • The average Advaxis stock price for the last 52 weeks is 0.64.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Advaxis Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 2.4571 4.4228 7.6012 0.2485 0.8577 -69.89%
2018 22.4771 46.4768 48.5757 2.7811 2.8486 -93.31%
2017 97.2542 112.2939 143.9280 42.2789 42.5787 -60.34%
2016 134.3328 141.0795 239.5802 81.8591 107.3463 -28.83%
2015 221.1246 126.2369 431.3343 105.2474 150.8246 25.59%
2014 54.2950 61.1694 134.9325 37.6312 120.0900 88.92%
2013 97.5185 56.2219 262.3688 40.4798 63.5682 13.07%
2012 175.1124 299.8501 318.5907 56.2219 56.2219 -81.25%
2011 279.1759 224.8876 449.7751 224.8876 299.8501 33.33%
2010 294.9418 243.6282 431.0345 187.4063 224.8876 -14.29%
2009 159.5928 37.4813 318.5907 37.4813 262.3688 600.00%
2008 151.5991 318.5907 318.5907 24.3628 37.4813 -88.24%
2007 429.7652 374.8126 805.8471 262.3688 318.5907 -5.56%
2006 406.8434 393.5532 562.2189 262.3688 337.3313 -14.29%
2005 461.6384 843.3283 937.0315 299.8501 393.5532 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.029B $0.021B
Advaxis, Inc. is a development stage biotechnology company focused on developing safe and effective cancer vaccines that utilize multiple mechanisms of immunity. The Company is developing a live Listeria vaccine technology under license from the University of Pennsylvania which secretes a protein sequence containing a tumor-specific antigen. The Company believes this vaccine technology is capable of stimulating the body's immune system to process and recognize the antigen as if it were foreign, generating an immune response able to attack the cancer. It also considers this to be a broadly enabling platform technology that can be applied to the treatment of many types of cancers, infectious diseases and auto-immune disorders. The Company's products in development include Lovaxin C and Lovaxin B, Lovaxin P.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $135.015B 10.40
Amgen (AMGN) United States $131.717B 14.31
CSL (CSLLY) Australia $95.198B 0.00
Gilead Sciences (GILD) United States $75.173B 10.82
Regeneron Pharmaceuticals (REGN) United States $62.318B 23.83
Vertex Pharmaceuticals (VRTX) United States $53.956B 30.11
Illumina (ILMN) United States $46.583B 54.17
Biogen (BIIB) United States $39.511B 7.02
Seattle Genetics (SGEN) United States $34.074B 0.00
Moderna (MRNA) United States $27.716B 0.00
BeiGene (BGNE) Cayman Islands $27.306B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.467B 11.03
Genmab (GMAB) Denmark $22.905B 14.45
Genmab (GNMSF) Denmark $21.264B 4.90
Incyte (INCY) United States $19.779B 0.00
BioNTech SE (BNTX) Germany $18.764B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.541B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.079B 77.25
Exact Sciences (EXAS) United States $16.003B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.953B 37.33
Alnylam Pharmaceuticals (ALNY) United States $14.922B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.942B 101.16
MyoKardia (MYOK) United States $11.820B 0.00
ARGENX SE-ADR (ARGX) Netherlands $11.725B 0.00
QIAGEN (QGEN) Netherlands $11.219B 28.47
Sarepta Therapeutics (SRPT) United States $10.882B 0.00
Guardant Health (GH) United States $10.231B 0.00
Bio-Techne Corp (TECH) United States $10.200B 69.99
Repligen (RGEN) United States $9.321B 147.95
Mirati Therapeutics (MRTX) United States $8.760B 0.00
Ascendis Pharma (ASND) Denmark $8.382B 0.00
Galapagos (GLPG) Belgium $8.316B 30.09
ACADIA Pharmaceuticals (ACAD) United States $7.075B 0.00
Adaptive Biotechnologies (ADPT) United States $6.783B 0.00
Exelixis (EXEL) United States $6.767B 24.61
CRISPR Therapeutics AG (CRSP) Switzerland $6.605B 204.63
Acceleron Pharma (XLRN) United States $6.493B 0.00
Blueprint Medicines (BPMC) United States $5.702B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.529B 0.00
Novavax (NVAX) United States $5.354B 0.00
Emergent Biosolutions (EBS) United States $5.043B 19.98
SWEDISH ORP BIO (BIOVF) Sweden $4.959B 13.55
Arena Pharmaceuticals (ARNA) United States $4.929B 0.00
Amicus Therapeutics (FOLD) United States $4.852B 0.00
NeoGenomics (NEO) United States $4.633B 1398.33
Vir Biotechnology (VIR) United States $4.545B 0.00
Denali Therapeutics (DNLI) United States $4.460B 0.00
China Biologic Products (CBPO) China $4.445B 26.38
Halozyme Therapeutics (HALO) United States $4.225B 0.00
Fate Therapeutics (FATE) United States $4.073B 0.00
Reata Pharmaceuticals (RETA) United States $3.852B 0.00
Insmed (INSM) United States $3.744B 0.00
Twist Bioscience (TWST) United States $3.688B 0.00
Legend Biotech (LEGN) United States $3.581B 0.00
Bluebird Bio (BLUE) United States $3.544B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.537B 0.00
Global Blood Therapeutics (GBT) United States $3.469B 0.00
MorphoSys AG (MOR) Germany $3.346B 43.85
Eidos Therapeutics (EIDX) United States $2.826B 0.00
Alkermes (ALKS) Ireland $2.530B 53.03
PHARMA MAR SA (PHMMF) Spain $2.396B 0.00
I-Mab (IMAB) China $2.350B 0.00
Seres Therapeutics (MCRB) United States $2.276B 0.00
Sorrento Therapeutics (SRNE) United States $2.073B 0.00
Editas Medicine (EDIT) United States $2.001B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.938B 0.00
UniQure (QURE) Netherlands $1.931B 0.00
Amarin (AMRN) Ireland $1.901B 0.00
Zymeworks (ZYME) Canada $1.862B 0.00
Beam Therapeutics (BEAM) United States $1.846B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Viela Bio (VIE) United States $1.754B 0.00
Inovio Pharmaceuticals (INO) United States $1.751B 0.00
Intra-Cellular Therapies (ITCI) United States $1.673B 0.00
Revance Therapeutics (RVNC) United States $1.658B 0.00
Sangamo Therapeutics (SGMO) United States $1.578B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.513B 0.00
Intellia Therapeutics (NTLA) United States $1.439B 0.00
Zealand Pharma (ZEAL) Denmark $1.404B 0.00
Ligand Pharmaceuticals (LGND) United States $1.366B 46.16
Northwest Biotherapeutics (NWBO) United States $1.329B 0.00
Mersana Therapeutics (MRSN) United States $1.312B 0.00
Arcus Biosciences (RCUS) United States $1.288B 0.00
Epizyme (EPZM) United States $1.282B 0.00
Mesoblast (MESO) Australia $1.278B 0.00
Coherus BioSciences (CHRS) United States $1.269B 7.40
Zealand Pharma (ZLDPF) Denmark $1.264B 0.00
Alcobra (ARCT) United States $1.223B 0.00
NGM Biopharmaceuticals (NGM) United States $1.193B 0.00
Cytokineticsorporated (CYTK) United States $1.093B 0.00
REGENXBIO (RGNX) United States $1.085B 0.00
Heska (HSKA) United States $1.083B 0.00
Myriad Genetics (MYGN) United States $1.074B 0.00
Retrophin (RTRX) United States $1.069B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.058B 0.00
Genetron Holdings (GTH) China $1.019B 0.00
Castle Biosciences (CSTL) United States $1.003B 0.00
NantKwest (NK) United States $0.975B 0.00
Adverum Biotechnologies (ADVM) United States $0.958B 0.00
Athenex (ATNX) United States $0.955B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.951B 0.00
Compugen (CGEN) Israel $0.950B 0.00
Vericel (VCEL) United States $0.920B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.846B 0.00
Morphic Holding (MORF) United States $0.835B 0.00
Codexis (CDXS) United States $0.827B 0.00
Arvinas (ARVN) United States $0.826B 0.00
Pliant Therapeutics (PLRX) United States $0.805B 0.00
Alector (ALEC) United States $0.778B 0.00
AnaptysBio (ANAB) United States $0.757B 0.00
Cellectis S.A (CLLS) France $0.755B 0.00
Frequency Therapeutics (FREQ) United States $0.751B 0.00
Intrexon (PGEN) United States $0.733B 0.00
Protagonist Therapeutics (PTGX) United States $0.713B 0.00
Pharming Group (PHGUF) Netherlands $0.682B 15.57
Agenus (AGEN) United States $0.670B 0.00
MiMedx (MDXG) United States $0.656B 0.00
Cara Therapeutics (CARA) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Adaptimmune Therapeutics (ADAP) United Kingdom $0.634B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.631B 0.00
Celldex Therapeutics (CLDX) United States $0.603B 0.00
Kadmon Holdings (KDMN) United States $0.581B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.570B 4.99
VBI Vaccines (VBIV) United States $0.569B 0.00
Geron (GERN) United States $0.568B 0.00
IVERIC Bio (ISEE) United States $0.534B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.503B 0.00
Cel-Sci (CVM) United States $0.499B 0.00
Albireo Pharma (ALBO) United States $0.495B 0.00
Anika Therapeutics (ANIK) United States $0.492B 21.52
MeiraGTx Holdings (MGTX) United States $0.486B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.486B 0.00
MannKind (MNKD) United States $0.477B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.472B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.468B 0.00
Clovis Oncology (CLVS) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.453B 0.00
UROGEN PHARMA (URGN) United States $0.440B 0.00
Sutro Biopharma (STRO) United States $0.439B 0.00
Amryt Pharma (AMYT) United Kingdom $0.438B 0.00
Kala Pharmaceuticals (KALA) United States $0.433B 0.00
Dynavax Technologies (DVAX) United States $0.430B 0.00
Avid Bioservices (CDMO) United States $0.428B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.424B 0.00
Starpharma Holdings (SPHRY) Australia $0.419B 0.00
Scholar Rock Holding (SRRK) United States $0.410B 0.00
Merus (MRUS) Netherlands $0.380B 0.00
Puma Biotechnology (PBYI) United States $0.378B 0.00
Forte Biosciences (FBRX) United States $0.373B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.367B 0.00
Cue Biopharma (CUE) United States $0.363B 0.00
Cellular Biomedicine (CBMG) United States $0.356B 0.00
ANI Pharmaceuticals (ANIP) United States $0.351B 8.29
Kamada (KMDA) Israel $0.350B 16.72
AC Immune SA (ACIU) Switzerland $0.348B 0.00
Trevena (TRVN) United States $0.342B 0.00
Spero Therapeutics (SPRO) United States $0.342B 0.00
Cardiff Oncology (CRDF) United States $0.340B 0.00
Precision BioSciences (DTIL) United States $0.340B 0.00
Selecta Biosciences (SELB) United States $0.335B 0.00
Athersys (ATHX) United States $0.334B 0.00
IBio (IBIO) United States $0.334B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.331B 0.00
BioDelivery Sciences (BDSI) United States $0.329B 23.29
Aeglea BioTherapeutics (AGLE) United States $0.323B 0.00
Innate Pharma S.A (IPHA) France $0.316B 0.00
Syros Pharmaceuticals (SYRS) United States $0.313B 0.00
CytomX Therapeutics (CTMX) United States $0.307B 0.00
NextCure (NXTC) United States $0.301B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.295B 0.00
ChromaDex (CDXC) United States $0.294B 0.00
WAVE Life Sciences (WVE) Singapore $0.279B 0.00
XOMA (XOMA) United States $0.259B 0.00
PDL BioPharma (PDLI) United States $0.254B 0.00
Affimed (AFMD) Germany $0.245B 0.00
Pluristem Therapeutics (PSTI) Israel $0.243B 0.00
TELA Bio (TELA) United States $0.236B 0.00
Arbutus Biopharma (ABUS) United States $0.229B 0.00
Fortress Biotech (FBIO) United States $0.222B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.216B 0.00
Dyadic (DYAI) United States $0.212B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
Verastem (VSTM) United States $0.207B 0.00
Five Prime Therapeutics (FPRX) United States $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Eton Pharmaceuticals (ETON) United States $0.184B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.180B 0.00
CorMedix Inc (CRMD) United States $0.177B 0.00
Liquidia Technologies (LQDA) United States $0.169B 0.00
GENFIT S.A (GNFT) France $0.169B 0.00
Cerecor (CERC) United States $0.169B 0.00
DBV Technologies S.A (DBVT) France $0.168B 0.00
Biofrontera AG (BFRA) Germany $0.166B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.159B 0.00
Kindred Biosciences (KIN) United States $0.158B 0.00
Theratechnologies (THTX) Canada $0.156B 0.00
Nicox SA (NICXF) France $0.149B 0.00
VolitionRX (VNRX) United States $0.146B 0.00
Bellus Health (BLU) Canada $0.145B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.144B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.144B 6.70
Checkpoint Therapeutics (CKPT) United States $0.142B 0.00
Aptinyx (APTX) United States $0.140B 0.00
Applied Genetic Technologies (AGTC) United States $0.137B 0.00
Prometic Life Sciences (LMNL) Canada $0.135B 0.00
Exicure (XCUR) United States $0.134B 0.00
SESEN BIO, INC (SESN) United States $0.130B 0.00
Aytu Bioscience (AYTU) United States $0.128B 0.00
Cidara Therapeutics (CDTX) United States $0.128B 0.00
AquaBounty Technologies (AQB) United States $0.126B 0.00
Catalyst Biosciences (CBIO) United States $0.126B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.125B 0.00
Unum Therapeutics (COGT) United States $0.124B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.113B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Strongbridge Biopharma (SBBP) United States $0.111B 0.00
Gritstone Oncology (GRTS) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.109B 5.53
Abeona Therapeutics (ABEO) United States $0.107B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.102B 0.00
Antibe Therapeutics (ATBPF) Canada $0.099B 0.00
Oncobiologics (OTLK) United States $0.097B 0.00
AIT Therapeutics (XAIR) United States $0.096B 0.00
Enzo Biochem (ENZ) United States $0.095B 0.00
Palatin Technologies (PTN) United States $0.089B 0.00
Cyclerion Therapeutics (CYCN) United States $0.088B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.086B 0.00
Ecology Coatings (ABVC) United States $0.086B 0.00
Idera Pharmaceuticals (IDRA) United States $0.083B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
ARAVIVE, INC (ARAV) United States $0.079B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
Stealth BioTherapeutics (MITO) United States $0.075B 72.00
Prima BioMed (IMMP) Australia $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Appili Therapeutics (APLIF) Canada $0.064B 0.00
AmpliPhi Biosciences (ARMP) United States $0.062B 0.00
Clearside Biomedical (CLSD) United States $0.061B 0.00
Curis (CRIS) United States $0.060B 0.00
Edesa Biotech (EDSA) Canada $0.060B 0.00
TRACON Pharmaceuticals (TCON) United States $0.057B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.055B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.054B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.052B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Cocrystal Pharma (COCP) United States $0.045B 0.00
Genetic Technologies (GENE) Australia $0.045B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Acorda Therapeutics (ACOR) United States $0.043B 0.00
Novogen (KZIA) Australia $0.041B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
Vaccinex (VCNX) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
Pulmatrix (PULM) United States $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Apricus Biosciences (SEEL) United States $0.034B 0.00
Cleveland BioLabs (CBLI) United States $0.033B 0.00
ATyr Pharma (LIFE) United States $0.033B 0.00
OvaScience (MLND) United States $0.031B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Celsion (CLSN) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Alimera Sciences (ALIM) United States $0.022B 0.00
Spherix (AIKI) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00